The following sections will assist healthcare professionals and payers by providing appropriate coding and billing information associated with the treatment of lung cancer.
The following sections include:
- Associated ICD-9-CM codes used for the classification of lung cancer
- Drugs that have been FDA approved in the treatment of lung cancer
- Drugs that are Compendia-listed for off-label use for lung cancer based on clinical studies that suggest beneficial use in some cases. Please note: If a check mark appears in the FDA column, it will NOT appear in the Compendia off-label use column
- Corresponding HCPCS/CPT® codes and code descriptions
- Drugs listed in the Compendia section have no FDA-approved uses for lung cancer. However, drugs in the FDA-approved section are FDA approved for at least 1 of the lung cancer ICD-9-CM codes but may also have Compendia-listed uses as well